Predict your next investment

Venture Capital
gdlangels.mx

See what CB Insights has to offer

Investments

3

About GAIN

Seed stage investment firm focused on Information Technology, mobile, healthcare, greentech, and social impact startups.

GAIN Headquarter Location

65265,

Mexico

52(333)808-7820

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest GAIN News

Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 17, 2021

* a replay will be available following the presentation for 90 days Please contact your representative at Oppenheimer & Co. to schedule a virtual one-on-one meeting with Gain Therapeutics during the respective conference. For more information about the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, please refer to the conference website . About Gain Therapeutics, Inc. Gain Therapeutics, Inc. is positioned at the confluence of technology and healthcare and focused on redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding. Gain was established in 2017 with the support of its founders and institutional investors. It has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, as well as from the Eurostars-2 joint program with co-funding from the European Union Horizon 2020 research and Innosuisse. In July 2020, Gain Therapeutics, Inc. completed a share exchange with Gain Therapeutics, SA, a Swiss corporation, whereby GT Gain Therapeutics SA became a wholly owned subsidiary of Gain Therapeutics, Inc. For periods and at dates prior to the Corporate Reorganization, the consolidated financial statements were prepared based on the historical financial statements of GT Gain Therapeutics SA. For more information, please visit  https://www.gaintherapeutics.com Forward-Looking Statements Any statements in this release that are not historical facts may be considered to be “forward-looking statements.” Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Such statements include, but are not limited to, statements regarding the market opportunity for Gain’s product candidates, and the business strategies and development plans of Gain. Some of the potential risks and uncertainties that could cause actual results to differ from those expected include Gain’s ability to: make commercially available its products and technologies in a timely manner or at all; enter into strategic alliances, including arrangements for the development and distribution of its products; obtain intellectual property protection for its assets; accurately estimate and manage its expenses and cash burn and raise additional funds when necessary. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Gain does not undertake any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events. Investor & Media Contacts:

GAIN Investments

3 Investments

GAIN has made 3 investments. Their latest investment was in VoxFeed as part of their Seed on June 6, 2015.

CBI Logo

GAIN Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/24/2015

Seed

VoxFeed

$1.75M

No

Agave Lab, Cambrian Ventures, NAZCA, and Undisclosed Investors

1

8/19/2013

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

3/26/2009

Seed

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2015

8/19/2013

3/26/2009

Round

Seed

Seed VC

Seed

Company

VoxFeed

Subscribe to see more

Subscribe to see more

Amount

$1.75M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Agave Lab, Cambrian Ventures, NAZCA, and Undisclosed Investors

Sources

1

10

10

GAIN Team

2 Team Members

GAIN has 2 team members, including current Chief Executive Officer, Juan Jose Daboub A..

Name

Work History

Title

Status

Juan Jose Daboub A.

ANTEL, Princeton University, UN Climate Change, and World Bank

Chief Executive Officer

Current

Rodrigo Ramirez Organista

Chief Executive Officer

Current

Name

Juan Jose Daboub A.

Rodrigo Ramirez Organista

Work History

ANTEL, Princeton University, UN Climate Change, and World Bank

Title

Chief Executive Officer

Chief Executive Officer

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.